Is Silent Treatment a Hit or Flop? Official Box Office Record & Profit Analysis
The official verdict is out. With a worldwide gross of $200.0M, Silent Treatment is declared a Blockbuster.
Box Office Snapshot
Detailed Verdict Analysis
Detailed Financial Report
Silent Treatment, released in 2013, entered the cinematic marketplace as a Drama / Romance film. The production path for this project involved significant capital, with a reported budget of approximately $50.0M. In the modern film economy, recovering such an investment requires a multifaceted theatrical strategy spanning domestic and international territories.
Collection Trajectory
The box office journey for Silent Treatment has culminated in a worldwide gross of approximately $200.0M. This figure represents the total theatrical footprint, reflecting a Return on Investment (ROI) of 300%. Such a robust financial display underscores the film's broad appeal and effective marketing campaign.
Profitability & Verdict
Analyzing the multiplier effect and market sentiment, Silent Treatment navigated the competitive landscape with an audience reception score of 7.5/10. When weighing the production costs against the global returns, Silent Treatment is effectively categorized as a Blockbuster. It stands as a testament to the power of high-concept storytelling and broad audience appeal.
Comparables
In the context of other Drama releases, the performance of Silent Treatment will likely influence how studios approach similar projects in the future. Whether through its innovative visual style or its narrative choices, the film's financial footprint remains a key piece of the 2013 box office narrative.
Audience Reception
Apart from the financial numbers, the audience sentiment plays a crucial role. Not all box office hits are loved, and not all flops are bad movies.